Webinar - Bispecific Antibodies: The Next Generation of Antibody Therapeutics

(43:38)

Developing Antibodies for Covid-19

(5:16)

Developing a portfolio of first-in-class immune-oncology antibodies

(1:3:9)

Monoclonal Antibodies and its Production

(3:32)

Mechanistic model-informed discovery \u0026 development of bispecific antibodies for immuno-oncology

(55:53)

Monoclonal antibodies in medicine

(4:46)

Creating $122 Billion of Antibodies | History of Antibodies

(6:)

How to Overcome Assay Challenges Using Custom Recombinant Antibodies

(35:40)

James Harrison| The man with Golden Arm| @RuthviTalks7 #trendingshorts #australia #blooddonor

(1:38)

How To Improve Your Antibody Drug Development Assays with Anti-Idiotypic Antibodies

(30:59)

Functional Assays for the Development of Agonistic Antibodies

(51:34)

What are antibodies? Why is developing them for COVID-19 so complicated?

(4:5)

Explained Simply: Coronavirus Antibody Testing, Convalescent Plasma \u0026 Monoclonal Antibodies Research

(5:34)

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

(11:49)

Recombinant Antibodies with SpyTag Technology

(25:20)

Developing antibodies to prevent pathological tau spreading in Alzheimer’s disease

(3:14)

Development of Monoclonal Antibodies - Creative Biolabs

(8:34)

Dr Rebecca Nisbet | Developing antibodies to fight dementia-causing brain proteins

(2:52)

The Humoral Response - B Cell Activation, Antibody Production \u0026 Memory Cells

(5:44)

Transform Your Bioanalytical Assay Development with TrailBlazer Antibodies

(33:10)